Home › Borstkanker › New Jersey
Borstkanker klinische studies in New Jersey
93 studies voor Borstkanker zoeken deelnemers op locaties in New Jersey.
Steden in New Jersey
- Edison68 studies
- Newark18 studies
- Clifton12 studies
- Elizabeth10 studies
- Trenton10 studies
- Camden8 studies
- Paterson7 studies
- Brick6 studies
- Toms River4 studies
- Jersey City3 studies
Officiële studietekst (Engels)
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
- MD Anderson Cancer Center At Cooper, Camden
- Summit Health, Florham Park
- The Valley Hospital, Ridgewood
RekruterenFase 3
Leeftijden 18 tot 100 · Alle geslachten · Bijgewerkt 2 okt. 2026 · NCT05827081A Study on Adding Precisely Targeted Radiation Therapy (Stereotactic Body Radiation Therapy) to the Usual Treatment Approach (Drug Therapy) in People With Breast Cancer
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown
- Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale
RekruterenFase 2
Leeftijden 18 en ouder · Alle geslachten · Bijgewerkt 2 okt. 2026 · NCT05534438Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Englewood Hospital and Medical Center, Englewood
- Hackettstown Medical Center, Hackettstown
- Morristown Medical Center, Morristown
- en nog 6
RekruterenObservatieonderzoekGezonde vrijwilligers welkom
Leeftijden 40 tot 75 · Alle geslachten · Bijgewerkt 2 okt. 2026 · NCT05334069A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer
- Astera Cancer Care (Formerly Regional Cancer Care Associates), East Brunswick
- Medical Oncology Hematology Associates, Newark
RekruterenFase 2
Leeftijden 18 en ouder · Alle geslachten · Bijgewerkt 1 okt. 2026 · NCT07102381A Study of a One-Time Counseling Session to Help Reduce Depression, Anxiety, and Distress in People With Cancer
- Memorial Sloan Kettering Basking Ridge (Consent Only), Basking Ridge
- Memorial Sloan Kettering Monmouth (Consent Only), Middletown
- Memorial Sloan Kettering Bergen (Consent Only), Montvale
Rekruteren
Leeftijden 18 en ouder · Alle geslachten · Bijgewerkt 30 sep. 2026 · NCT07218250A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
- Research Site, New Brunswick
RekruterenFase 1
Leeftijden 18 en ouder · Alle geslachten · Bijgewerkt 29 sep. 2026 · NCT05877599A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)
- John Theurer Cancer Center at Hackensack University Medical Center ( Site 0001), Hackensack
- Rutgers Cancer Institute of New Jersey ( Site 0033), New Brunswick
RekruterenFase 3
Leeftijden 18 en ouder · Alle geslachten · Bijgewerkt 28 sep. 2026 · NCT07060807Multicenter Trial for Eliminating Breast Cancer Surgery or Radiotherapy in Exceptional Responders to Neoadjuvant Systemic Therapy
- Cooper Hospital Univ Med Ctr, MD Anderson at Cooper Voorhees, Voorhees Township
Rekruteren
Leeftijden 30 en ouder · Vrouwen · Bijgewerkt 25 sep. 2026 · NCT02945579A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
- Hackensack Univ Medical Center (HUMC) ( Site 0007), Hackensack
- Rutgers Cancer Institute of New Jersey ( Site 0076), New Brunswick
RekruterenFase 3
Leeftijden 18 en ouder · Alle geslachten · Bijgewerkt 25 sep. 2026 · NCT06966700The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study
- Englewood Hospital, Englewood
- Capital Health Medical Center - Hopewell, Pennington
- Penn Medicine - Princeton Health, Plainsboro
RekruterenFase 3
Leeftijden 60 en ouder · Alle geslachten · Bijgewerkt 25 sep. 2026 · NCT06377852A Study of Language Interpretation Solutions for People With Breast Cancer
- Memorial Sloan Kettering Basking Ridge (Consent Only), Basking Ridge
- Memorial Sloan Kettering Monmouth (Consent Only), Middletown
- Memorial Sloan Kettering Bergen (Consent Only), Montvale
Rekruteren
Leeftijden 18 en ouder · Alle geslachten · Bijgewerkt 25 sep. 2026 · NCT06721065A Study of an Alternative Treatment Approach (Preoperative Radiotherapy, Then Mastectomy, Then Immediate Reconstruction Surgery) in People With T4 Breast Cancer
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown
- Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale
RekruterenFase 1
Leeftijden 18 en ouder · Vrouwen · Bijgewerkt 24 sep. 2026 · NCT05412225A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors
- John Theurer Cancer Center at Hackensack University Medical Center, Hackensack
RekruterenFase 1/2
Leeftijden 18 en ouder · Alle geslachten · Bijgewerkt 23 sep. 2026 · NCT06618287Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
- Cooper Health, Camden
- Rutgers, New Brunswick
Rekruteren
Leeftijden 18 en ouder · Alle geslachten · Bijgewerkt 23 sep. 2026 · NCT07214532A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
- Jefferson Health - Cherry Hill, Cherry Hill
- Sidney Kimmel Cancer Center - Washington Township, Sewell
- Atlantic Health System Overlook Medical Center, Summit
RekruterenFase 3
Leeftijden 18 en ouder · Alle geslachten · Bijgewerkt 22 sep. 2026 · NCT07174336Study of 3-Day Partial Breast Radiation Therapy in Women With Breast Cancer
- Memorial Sloan Kettering Basking Ridge, Basking Ridge
- Memorial Sloan Kettering Monmouth, Middletown
- Memorial Sloan Kettering Bergen, Montvale
RekruterenFase 2
Leeftijden 45 en ouder · Vrouwen · Bijgewerkt 21 sep. 2026 · NCT04084730ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
- Summit Medical Group PA, Florham Park
- Rutgers Cancer Institute of NJ (Rutgers, The State University of New Jersey), Livingston
- Rutgers Cancer Institute of NJ (Rutgers, The State University of New Jersey), Long Branch
- en nog 4
RekruterenFase 3
Leeftijden 18 en ouder · Alle geslachten · Bijgewerkt 17 sep. 2026 · NCT07173751A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer
- Memorial Sloan Kettering Cancer Center Basking Ridge, Basking Ridge
- Summit Medical Group, Florham Park
- Memorial Sloan Kettering Cancer Center Monmouth, Middletown
- en nog 1
RekruterenFase 1/2
Leeftijden 18 en ouder · Alle geslachten · Bijgewerkt 17 sep. 2026 · NCT06827236A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
- MD Anderson Cancer Center at Cooper, Camden
- Summit Medical Group, Florham Park
- John Theurer Ctr-Hackensack UMC, Hackensack
- en nog 1
RekruterenFase 3
Leeftijden 18 en ouder · Alle geslachten · Bijgewerkt 15 sep. 2026 · NCT06492616A Study of Pembrolizumab and Ablation (Cryoablation or Histotripsy) in People With Breast Cancer
- Memorial Sloan Kettering Cancer Center at Basking Ridge (Limited Protocol Activities), Basking Ridge
- Memorial Sloan Kettering Monmouth (Limited protocol activities), Middletown
- Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale
RekruterenFase 1
Leeftijden 18 en ouder · Alle geslachten · Bijgewerkt 14 sep. 2026 · NCT06246968A Study of Multiparametric MRI and pHLIP® ICG in Breast Cancer Imaging During Surgery
- Memorial Sloan Kettering Bergen (All Protocol Activities), Montvale
RekruterenFase 1/2
Leeftijden 18 en ouder · Vrouwen · Bijgewerkt 11 sep. 2026 · NCT05130801Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
- START - New Jersey, East Brunswick
RekruterenFase 1
Leeftijden 18 en ouder · Alle geslachten · Bijgewerkt 10 sep. 2026 · NCT06293898A Phase 1/1b Study of IAM1363 in HER2 Cancers
- Rutgers Cancer Institute, New Brunswick
RekruterenFase 1
Leeftijden 18 en ouder · Alle geslachten · Bijgewerkt 9 sep. 2026 · NCT06253871A Study of SDX-7320 in Combination With Eribulin for People With Breast Cancer
- Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge
- Hackensack Meridian Health, Hackensack
- Memorial Sloan Kettering Monmouth (All Protocol Activities), Middletown
- en nog 1
RekruterenFase 2
Leeftijden 18 en ouder · Alle geslachten · Bijgewerkt 9 sep. 2026 · NCT05570253A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast Cancer
- Rutgers Cancer Institute of New Jersey, New Brunswick
RekruterenFase 1/2
Leeftijden 18 en ouder · Alle geslachten · Bijgewerkt 8 sep. 2026 · NCT07100106To Study the Effect of Inavolisib in Combination With Fulvestrant in Participants With Breast Cancer
- Astera Cancer Care East Brunswick, East Brunswick
RekruterenFase 2
Leeftijden 18 en ouder · Alle geslachten · Bijgewerkt 4 sep. 2026 · NCT07368998Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
- John Theurer Cancer Center at Hackensack University Medical Center, Hackensack
- Rutgers Cancer Institute, New Brunswick
RekruterenFase 3
Leeftijden 18 en ouder · Alle geslachten · Bijgewerkt 3 sep. 2026 · NCT06982521Evaluating Minimal Residual Disease (MRD) Through Longitudinal Circulating Tumor DNA (ctDNA) Profiling in Breast Malignancies
- Summit Medical Group, Florham Park
RekruterenObservatieonderzoek
Leeftijden 18 tot 99 · Alle geslachten · Bijgewerkt 3 sep. 2026 · NCT07211178A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
- Astera Cancer Care East Brunswick, East Brunswick
- Summit Medical Group, Florham Park
RekruterenFase 3
Leeftijden 18 en ouder · Alle geslachten · Bijgewerkt 3 sep. 2026 · NCT06790693Observational Study of Bone Complications in People With Post-menopausal Breast Cancer Who Have Stopped Treatment With Denosumab and Aromatase Inhibitors
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown
- Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale
RekruterenObservatieonderzoek
Leeftijden 18 en ouder · Vrouwen · Bijgewerkt 3 sep. 2026 · NCT05590949A Study of ASP2998 Given by Itself and Given With Standard Therapies in People With Solid Tumors
- John Theurer Cancer Center at Hackensack University Medical Center, Hackensack
RekruterenFase 1/2
Leeftijden 18 en ouder · Alle geslachten · Bijgewerkt 2 sep. 2026 · NCT07287995Shortening Adjuvant Photon and Proton Irradiation (SAPPHIRe-II): A 4 Cohort, Randomized, Phase II Multi-center Trial Evaluating Shorter Schedules of Adjuvant Regional Nodal Irradiation Among Women and Men With Node-positive and High-risk Node-negative Invasive Breast Cancer
- Cooper Hospital University Medical Center, Voorhees Township
RekruterenFase 2
Leeftijden 18 en ouder · Alle geslachten · Bijgewerkt 2 sep. 2026 · NCT07076485A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown
- Memorial Sloan Kettering Bergen (Limited protocol activities), Montvale
Rekruteren
Leeftijden 18 en ouder · Alle geslachten · Bijgewerkt 2 sep. 2026 · NCT05837767Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
- Cooper Hospital University Medical Center, Camden
- Jefferson Cherry Hill Hospital, Cherry Hill
- Trinitas Hospital and Comprehensive Cancer Center - Williamson Street Campus, Elizabeth
- en nog 21
RekruterenFase 3
Leeftijden 18 tot 60 · Vrouwen · Bijgewerkt 2 sep. 2026 · NCT05879926Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
- Hunterdon Medical Center, Flemington
RekruterenFase 3
Leeftijden 18 en ouder · Alle geslachten · Bijgewerkt 2 sep. 2026 · NCT06072612Study of Aerobic Training for People Receiving Treatment for Breast Cancer
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown
- Memorial Sloan Kettering Bergen (Limited protocol activities), Montvale
RekruterenFase 2
Leeftijden 18 en ouder · Vrouwen · Bijgewerkt 27 aug. 2026 · NCT05716893A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid Tumors
- START New Jersey, LLC, East Brunswick
RekruterenFase 1
Leeftijden 18 en ouder · Alle geslachten · Bijgewerkt 26 aug. 2026 · NCT07383506KK-LC-1 TCR-T Cell Therapy for Gastric, Breast, Cervical, and Lung Cancer
- Rutgers Cancer Institute, New Brunswick
- RWJBarnabas Health - Robert Wood Johnson University Hospital, New Brunswick
RekruterenFase 1
Leeftijden 18 en ouder · Alle geslachten · Bijgewerkt 25 aug. 2026 · NCT05483491A Phase 1 Study of LNCB74 in Advanced Solid Tumors
- John Theurer Cancer Ctr at Hackensack Univ. Med Ctr., Hackensack
RekruterenFase 1
Leeftijden 18 en ouder · Alle geslachten · Bijgewerkt 21 aug. 2026 · NCT06774963HERizon-Breast: A ctDNA-Guided Adaptive Study of Sequential Anti-HER2 Therapies and CNS Prophylaxis to Induce Long-Term Remission
- Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge
- Memorial Sloan Kettering at Monmouth (Limited Protocol Activities), Middletown
- Memorial Sloan Kettering at Bergen (Limited Protocol Activities), Montvale
RekruterenFase 2
Leeftijden 18 en ouder · Alle geslachten · Bijgewerkt 20 aug. 2026 · NCT07459673Van ClinicalTrials.gov, gegevens opgehaald op 5 okt. 2026. Elke studie stelt eigen deelnamecriteria vast; het studieteam bepaalt wie er kan deelnemen.